SPDR S&P Pharmaceuticals ETF Rating → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free XPH Stock Alerts $41.17 -0.11 (-0.27%) (As of 05/17/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 297 analyst ratings issued in the past year covering 40 companies (98.9% of the portfolio).XPH Aggregate Price Target$66.4961.49% UpsideHigh Prediction$85.58Average Prediction$66.49Low Prediction$47.48Holdings in XPH have an aggregate price target of $66.49 and a range of $47.48 to $85.58 covering 40 companies (98.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.35%ITCIIntra-Cellular Therapies$65.00-2.3%5 of 5 stars2.90$90.17 38.7%10Positive News5.24%MRKMerck & Co., Inc.$131.19+0.2%5 of 5 stars2.58$131.33 0.1%12Analyst RevisionNews Coverage5.13%PRGOPerrigo$29.83-0.9%5 of 5 stars3.00$40.67 36.3%3Analyst UpgradeOptions Volume4.96%OGNOrganon & Co.$21.80+1.3%5 of 5 stars2.50$22.60 3.7%44.88%CTLTCatalent$55.37+0.2%4 of 5 stars2.15$52.46 -5.3%13Short Interest ↓Positive News4.78%AXSMAxsome Therapeutics$76.54-1.0%4 of 5 stars2.92$121.92 59.3%134.75%LLYEli Lilly and Company$770.00-0.1%5 of 5 stars2.84$769.53 -0.1%19Analyst ForecastShort Interest ↓Analyst Revision4.65%VTRSViatris$10.98-0.4%1 of 5 stars1.33$11.00 0.2%34.60%PFEPfizer$28.64-1.0%5 of 5 stars2.40$35.86 25.2%154.59%JAZZJazz Pharmaceuticals$108.99-1.4%5 of 5 stars2.85$192.75 76.9%134.55%RPRXRoyalty Pharma$27.27-2.2%5 of 5 stars3.00$46.75 71.4%4Positive News4.52%JNJJohnson & Johnson$154.64+0.2%5 of 5 stars2.46$175.86 13.7%13Analyst ForecastShort Interest ↑4.29%ZTSZoetis$174.06+0.2%5 of 5 stars3.00$211.75 21.7%74.11%BMYBristol-Myers Squibb$44.03-0.2%5 of 5 stars2.11$60.00 36.3%193.98%ELANElanco Animal Health$17.19+1.2%3 of 5 stars2.57$18.29 6.4%7Short Interest ↓3.45%CORTCorcept Therapeutics$28.09+2.0%5 of 5 stars3.00$40.10 42.8%4Insider SellingShort Interest ↓Analyst RevisionNews Coverage2.54%ARVNArvinas$32.68+1.8%3 of 5 stars2.88$61.13 87.1%16Analyst ForecastNews Coverage2.17%AMPHAmphastar Pharmaceuticals$43.48+1.7%5 of 5 stars2.50$66.00 51.8%42.17%SAVACassava Sciences$23.12+7.2%3 of 5 stars3.00$131.00 466.6%1Analyst ForecastGap Up1.97%EYPTEyePoint Pharmaceuticals$11.84-5.4%2 of 5 stars3.00$33.71 184.7%7Insider SellingAnalyst RevisionNews Coverage1.70%TARSTarsus Pharmaceuticals$38.24-0.9%4 of 5 stars2.88$50.38 31.7%8Analyst Revision1.47%PBHPrestige Consumer Healthcare$64.65-0.5%4 of 5 stars2.33$95.00 46.9%3Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.25%PCRXPacira BioSciences$30.82-2.2%5 of 5 stars3.00$47.40 53.8%101.22%LBPHLongboard Pharmaceuticals$20.69+0.9%2 of 5 stars3.00$43.67 111.1%6Short Interest ↓1.18%HRMYHarmony Biosciences$29.03-1.0%4 of 5 stars2.50$40.63 39.9%8Positive News1.15%COLLCollegium Pharmaceutical$32.47-3.6%3 of 5 stars2.20$39.00 20.1%5Insider Selling1.00%LQDALiquidia$12.71-0.2%2 of 5 stars2.60$21.00 65.2%5Analyst ForecastAnalyst RevisionNews Coverage0.91%AMLXAmylyx Pharmaceuticals$1.834 of 5 stars2.25$28.67 1,466.5%8Earnings ReportAnalyst Forecast0.91%SUPNSupernus Pharmaceuticals$29.10-0.2%4 of 5 stars3.00$41.00 40.9%10.86%AMRXAmneal Pharmaceuticals$6.82+1.0%2 of 5 stars3.00$8.25 21.0%4Short Interest ↓0.81%LGNDLigand Pharmaceuticals$86.06+1.2%5 of 5 stars3.00$116.33 35.2%3Insider SellingNews Coverage0.65%ANIPANI Pharmaceuticals$61.43-3.7%5 of 5 stars3.00$81.00 31.9%4Insider SellingNews Coverage0.58%PLRXPliant Therapeutics$15.27-2.2%4 of 5 stars3.00$45.38 197.2%9Analyst Forecast0.57%RVNCRevance Therapeutics$3.02-4.4%4 of 5 stars2.50$11.50 280.8%80.46%EOLSEvolus$13.59-0.8%4 of 5 stars3.00$20.60 51.6%3Insider Selling0.39%TBPHTheravance Biopharma$9.29-3.2%2 of 5 stars3.00$20.50 120.7%2Analyst Forecast0.36%XERSXeris Biopharma$1.98-2.0%4 of 5 stars3.00$4.63 133.6%40.36%OCULOcular Therapeutix$6.17-1.6%4 of 5 stars2.83$15.17 145.8%6Gap Up0.28%FULCFulcrum Therapeutics$7.55-3.2%3 of 5 stars3.00$14.33 89.8%6Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.06%MRNSMarinus Pharmaceuticals$1.33+2.3%4 of 5 stars2.57$13.79 936.5%7News Coverage This page (NYSEARCA:XPH) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryNext President (Not Trump. Not Biden.)The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
